Long-term follow-up and role of FDG PET in advanced pancreatic neuroendocrine patients treated with 177Lu-D OTATATE.
about
The NETPET Score: Combining FDG and Somatostatin Receptor Imaging for Optimal Management of Patients with Metastatic Well-Differentiated Neuroendocrine Tumors.Reply to: Predicting the outcome of peptide receptor radionuclide therapy in neuroendocrine tumors: the importance of dual-tracer imaging.Predicting the outcome of peptide receptor radionuclide therapy in neuroendocrine tumors: the importance of dual-tracer imaging.
P2860
Long-term follow-up and role of FDG PET in advanced pancreatic neuroendocrine patients treated with 177Lu-D OTATATE.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Long-term follow-up and role o ...... treated with 177Lu-D OTATATE.
@en
Long-term follow-up and role o ...... treated with 177Lu-D OTATATE.
@nl
type
label
Long-term follow-up and role o ...... treated with 177Lu-D OTATATE.
@en
Long-term follow-up and role o ...... treated with 177Lu-D OTATATE.
@nl
prefLabel
Long-term follow-up and role o ...... treated with 177Lu-D OTATATE.
@en
Long-term follow-up and role o ...... treated with 177Lu-D OTATATE.
@nl
P2093
P2860
P50
P1476
Long-term follow-up and role o ...... treated with 177Lu-D OTATATE.
@en
P2093
Annarita Ianniello
Chiara Maria Grana
Emanuela Scarpi
Emilio Mezzenga
Fabio Ferroni
Lisa Bodei
Lorenzo Fantini
Maddalena Sansovini
Manuela Monti
Silvia Nicolini
P2860
P2888
P304
P356
10.1007/S00259-016-3533-Z
P577
2016-10-04T00:00:00Z